Seoul Gazette - Abbott apologizes for US baby formula shortage

"We are deeply sorry and are committed to making sure that a shortage like this never happens again," said Christopher Calamari, the senior vice president of nutrition, in testimony before Congress.

He said "it will take time" to regain families' trust, but the company is doing everything it can to resolve the crisis.

The United States has been struggling with a severe shortage of infant formula for months.

Initially caused by supply chain blockages and a lack of workers due to the pandemic, the shortage was exacerbated in February when, after the death of two infants, Abbott announced a "voluntary recall" for formula made at its factory in Michigan.

Regulators forced the company to shut down that location to resolve complaints it did not adequately protect against contamination from bacteria.

"Frankly, the inspection results were shocking," said FDA chief Robert Califf.

There was standing water in key equipment "that present the potential for bacterial contamination," leaks in the roof and a lack of basic hygiene facilities such as for washing hands, he said.

FDA teams concluded there was a weak culture of safety in production for an "essential" good, he said.

However, Calamari said, "we continue to believe that there is no conclusive evidence to link our formula" to the infant illnesses and deaths blamed on the bacteria Cronobacter sakazakii.

Though the organism was found in certain areas of the Michigan factory, the samples were taken from areas that "do not come into direct contact" with the formula, he said.

Abbott's Michigan plant is one of the largest formula factories in the United States, and produces specialized recipes for children with certain allergies or metabolic conditions.

- 'No choice' -

The FDA said it has made a series of visits to the Sturgis, Michigan location, the last on March 18.

"We knew that ceasing plant operations would create supply problems but we had no choice given the unsanitary conditions," Califf said.

The FDA director acknowledged that the investigation was slow to start, which he blamed on the pandemic. He said the agency could not start the probe until late January because of Abbott employees testing positive for Covid-19.

The agency's process was "too slow" and lacked coordination, Califf admitted, but there was no "intentional delay."

The crisis has gotten so bad that President Joe Biden announced last week that the US government would fly in formula on commercial planes contracted by the military. Biden also invoked the Defense Production Act to give baby formula manufacturers first priority in supplies.

The first military plane carrying more than 31 tons of formula from Germany landed Sunday at an airport in Indiana.

C. Fournier--BTZ